|
🐜
|
Drug treatments for covid-19: living systematic review and network meta-analysis
54 auth.
R. Siemieniuk,
J. Bartoszko,
L. Ge,
D. Zeraatkar,
A. Izcovich,
H. Pardo-Hernandez,
B. Rochwerg,
F. Lamontagne,
M. Han,
E. Kum,
Qin Liu,
A. Agarwal,
T. Agoritsas,
P. Alexander,
D. Chu,
...
R. Couban,
A. Darzi,
T. Devji,
Bo Fang,
Carmen Fang,
S. Flottorp,
F. Foroutan,
D. Heels-Ansdell,
K. Honarmand,
Liangying Hou,
Xiaorong Hou,
Quazi Ibrahim,
M. Loeb,
M. Marcucci,
S. McLeod,
S. Motaghi,
S. Murthy,
R. Mustafa,
J. Neary,
A. Qasim,
G. Rada,
I. Riaz,
B. Sadeghirad,
N. Sekercioglu,
Lulu Sheng,
Ashwini Sreekanta,
C. Switzer,
B. Tendal,
L. Thabane,
G. Tomlinson,
T. Turner,
P. Vandvik,
R. Vernooij,
A. Viteri-García,
Ying Wang,
L. Yao,
Z. Ye,
G. Guyatt,
R. Brignardello-Petersen
|
9 |
2020 |
9
🐜
|
|
🦁
|
Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus
7 auth.
N. Sekercioglu,
Chrysostomos Dimitriadis,
C. Pipili,
R. M. Elias,
Joseph Kim,
D. Oreopoulos,
...
J. Bargman
|
6 |
2012 |
6
🦁
|
|
🦁
|
Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis
11 auth.
N. Sekercioglu,
L. Thabane,
J. P. Diaz Martinez,
G. Nesrallah,
C. Longo,
J. Busse,
...
N. Akhtar-Danesh,
A. Agarwal,
R. Al-Khalifah,
A. Iorio,
G. Guyatt
|
6 |
2016 |
6
🦁
|
|
🐬
|
Cost-effectiveness of Deceased-donor Renal Transplant Versus Dialysis to Treat End-stage Renal Disease: A Systematic Review
Rui Fu,
N. Sekercioglu,
W. Berta,
P. Coyte
|
5 |
2020 |
5
🐬
|
|
🐬
|
Hyponatremia in Peritoneal Dialysis: Epidemiology in a Single Center and Correlation with Clinical and Biochemical Parameters
Chrysostomos Dimitriadis,
N. Sekercioglu,
C. Pipili,
D. Oreopoulos,
J. Bargman
|
5 |
2014 |
5
🐬
|
|
🦁
|
Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis
10 auth.
N. Sekercioglu,
J. Busse,
M. F. Sekercioglu,
A. Agarwal,
Shaun Shaikh,
L. Lopes,
...
R. Mustafa,
G. Guyatt,
L. Thabane,
M. Degroote
|
5 |
2016 |
5
🦁
|
|
🦁
|
A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument
12 auth.
N. Sekercioglu,
R. Al-Khalifah,
Joycelyne E Ewusie,
R. M. Elias,
L. Thabane,
J. Busse,
...
N. Akhtar-Danesh,
A. Iorio,
T. Isayama,
J. P. Martínez,
I. Flórez,
G. Guyatt
|
4 |
2017 |
4
🦁
|
|
🦁
|
Sleep quality and its correlates in patients with chronic kidney disease: a cross-sectional design
N. Sekercioglu,
B. Curtis,
S. Murphy,
B. Barrett
|
4 |
2015 |
4
🦁
|
|
🐬
|
Assessment of DNA Oxidation and Antioxidant Activity in Hypertensive Patients with Chronic Kidney Disease
Y. Dinçer,
N. Sekercioglu,
M. Pekpak,
K. N. Gunes,
T. Akçay
|
4 |
2008 |
4
🐬
|
|
🦁
|
Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA
8 auth.
N. Sekercioglu,
Argie Angeliki Veroniki,
L. Thabane,
J. Busse,
N. Akhtar-Danesh,
A. Iorio,
...
Luciane Cruz Lopes,
G. Guyatt
|
4 |
2017 |
4
🦁
|
